Wanbury receives Certificate of Suitability (CEP) for cough relief drug in Europe
The global formulation market for Dextromethorphan is valued at $2,500 million for FY24, a 7% growth over the previous year. This shows the growing demand for cough suppressants worldwide.
WANBURY
GLOBAL
Economy
Markets